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Background: Alterations in tendon matrix composition with aging and injury are poorly understood.
Results: Aging and injury resulted in distinct protein profiles, with age-specific peptide fragmentation in injury.
Conclusion: Identification of protein cleavages associated with aging and injury suggest impaired maintenance and repair in
aged tendon.
Significance: Novel peptide fragments identified are potential biomarkers of tendon injury and age-related degeneration.
Energy storing tendons, such as the human Achilles and
equine superficial digital flexor tendon (SDFT), are highly prone
to injury, the incidence of which increases with aging. The cel-
lular and molecular mechanisms that result in increased injury
in aged tendons are notwell establishedbut are thought to result
in altered matrix turnover. However, little attempt has been
made to fully characterize the tendon proteome nor determine
how the abundance of specific tendon proteins changes with
aging and/or injury. The aim of this study was, therefore, to
assess the protein profile of normal SDFTs from young and old
horses using label-free relative quantification to identify differ-
entially abundant proteins and peptide fragments between age
groups. The protein profile of injured SDFTs from young and
old horses was also assessed. The results demonstrate distinct
proteomic profiles in young and old tendon, with alterations in
the levels of proteins involved in matrix organization and regu-
lation of cell tension. Furthermore, we identified several new
peptide fragments (neopeptides) present in aged tendons, sug-
gesting that there are age-specific cleavage patterns within the
SDFT. Proteomic profile also differed between young and old
injured tendon, with a greater number of neopeptides identified
in young injured tendon. This study has increased the knowl-
edge of molecular events associated with tendon aging and
injury, suggesting that maintenance and repair of tendon tissue
may be reduced in aged individuals andmay help to explain why
the risk of injury increases with aging.
Current descriptions of tendon extracellular matrix (ECM)4
in the literature list the main components as collagen type I,
proteoglycans (predominantly small leucine-rich proteogly-
cans (SLRPs)) (1), minor collagens (types III, V, VI, XII) (2),
elastic fibers (3), and glycoproteins (4). Themost abundant pro-
tein, collagen type I, aligns with the tendon long axis and
aggregates in a series of hierarchical levels to form fibrils, fibers,
fascicles, and finally the whole tendon (5). At the larger hierar-
chical levels the collagen is interspersed with a proteoglycan-
rich matrix. This multilevel fiber composite organization
results in a tendon with high uniaxial strength that is able to
resist the large tensional forces experienced in vivo.
It is well established that tendon functional integrity
decreases with aging, predisposing aged tendons to degenera-
tion and injury (6, 7). Additional risk factors for tendon injury
include high levels of repetitive loading (8), genetic factors (9,
10), and chronic inflammation (11). However, the cellular and
molecularmechanisms underpinning this increased risk in ten-
dons are not well understood. Several studies have reported
alterations in matrix content as a function of aging, including
increased type III collagen (12), changes in cross-link profile as
a result of glycation (13, 14), and accumulation of partially
degraded collagen within the matrix (14). Age-related altera-
tions to the non-collagenous matrix have also been identified,
with decreased glycosaminoglycan and cartilage oligomeric
matrix protein (COMP) levels (15, 16). Several of these studies
indicate altered matrix turnover with aging. In cartilage, ECM
fragmentation patterns have demonstrated novel potential sub-
strates and cleavage sites for specific enzymes (17). Although a
recent study has identified stage-specific peptide fragments in
tendon disease (18), there is also a need to identify age-specific
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cleavage sites in tendon as this will enable the understanding
and distinction of the ECMdegradativemechanisms associated
with aging and disease.
It is important to further characterize the tendon ECM and
identify aging changes in both health and disease, as it is likely
that alterations to minor matrix components may have a pro-
found influence on tendon function. However, some minor
components of the tendon matrix may not yet have been iden-
tified. Although proteomic analysis has been used to identify
many novel proteins in other connective tissues such as carti-
lage (19, 20), a review of the current literature shows few studies
that have undertaken a proteomic analysis of tendon. Consid-
ering the studies that have addressed tendon proteomics, some
have assessed the proteins produced by tendon fibroblasts in
vitro (21, 22), whereas others have investigated alterations in
protein profile as a result of artificially induced injury (23, 24).
Smith et al. (25) investigated changes in pericellular proteins
during development, and Dakin et al. (18) studied normal and
diseased tendons from horses with a wide age range but do not
report any data regarding age-related alterations in protein
content. To the authors’ knowledge, no studies have assessed
age- and injury-associated changes in the tendon extracellular
matrix protein profile.
In the current study we used equine tendon tissue to study
the effect of aging and injury on tendon matrix composition.
The horse is an accepted and relevant model in which to study
musculoskeletal aging and injury, as it is a relatively long-lived
species in which age-related musculoskeletal diseases, such as
tendon injury, show a very similar epidemiology, etiology, and
pathology to that seen in human age-related musculoskeletal
diseases (14, 26–30). In both species the most commonly
injured tendons are those that store and return energy during
locomotion. In the human it is the Achilles tendon that is the
major energy store and the most prone to injury (31), whereas
in the horse, the predominant energy store is the superficial
digital flexor tendon (SDFT) (32). We, therefore, assessed the
protein profile of normal and injured SDFTs from young and
old horses using label-free relative quantification to identify
differentially abundant proteins between age groups. Further-
morewe investigated age-specific cleavage patterns in the ECM
by assessing fragmentation patterns of specific matrix mole-
cules to identify neopeptides in injured and aged tendon. One
way to provide new insights into the development and treat-
ment of tendon disease is to obtain an understanding of how
tendon undergoes the physiological remodeling that is evident
in aging. We hypothesized that we would identify age-related
alterations in ECMproteins and neopeptides within the tendon
matrix, with greater matrix fragmentation evident in injured
tendon.
EXPERIMENTAL PROCEDURES
All chemicals were supplied by Sigma unless otherwise
stated.
Tendon Sampling and Procurement—Forelimbs, distal to the
carpus, were collected from half to full thoroughbred horses
(young, 3.3  0.6 years; old, 19.0  1.7 years, both n  3),
euthanized at a commercial equine abattoir. Only tendons that
had no evidence of previous tendon injury at post-mortem
examination were included in the study. The SDFT was dis-
sected free from the limbs from the level of the carpus to the
metacarpophalangeal joint. Fascicles (length of 25 mm, diame-
ter of 0.2–0.4mm,weight of0.3 g)were dissected in duplicate
from the mid-metacarpal region of the tendon as described
previously (33). The fascicles were snap-frozen in liquid nitro-
gen and stored at80 °C until further analysis.
Protein Extraction and Sample Preparation—Each thawed
tendon sample (fascicle) was transferred into an Eppendorf
tube containing 200 l of 100 mM Tris acetate, protease
inhibitors (Complete Protease Inhibitors, EDTA-free, Roche
Applied Science), and 0.1 unit of chondroitinase ABC, pH 8.0,
and deglycosylated for 6 h at 37 °C. The supernatant was
removed after centrifugation at 13,000 g for 5 min. 0.5 ml of
guanidine extraction buffer (4 M guanidine hydrochloride
(GdnHCl), 65 mM dithiothreitol (DTT), and 50 mM sodium
acetate, pH 5.8) was added, and extraction was performed with
end-over-endmixing for 48 h at 4 °C. 25mMDTTwas added 2 h
before the addition of 80 mM iodoacetamide, the latter for the
last 2 h in the dark. The soluble fraction was removed after
centrifugation for 15 min at 13,000 g at 4 °C. The final insol-
uble fraction was incubated in 0.5 ml of 100 mM acetic acid
containing 100 g/ml pepsin overnight at 4 °C with end-over-
end mixing to release collagenous polypeptides. The superna-
tant was removed after centrifugation at 13,000 g for 15 min
at 4°C. This was lyophilized, resuspended in water, re-lyophi-
lized, and stored at80 °C. Protein concentrations of aliquots
of soluble fraction were estimated by the Bradford assay using
Coomassie PlusTM protein assay reagent (Thermo Scientific,
Rockford, IL) read at 660 nm after acetone precipitation.
One-dimensional Sodium Dodecyl Sulfate Polyacrylamide
Gel Electrophoresis (SDS-PAGE) and In-gel Trypsin Digestion—
TendonGdnHCl soluble extracts were analyzed by one-dimen-
sional SDS-PAGE to assess gross quantitative/qualitative dif-
ferences in protein profiles between young and old tendon.
Samples were loaded according to equal volumes after acetone
precipitation and resolubilization in buffer containing 8 M urea,
2% (w/v) CHAPS and 0.0002% (v/v) bromphenol blue plus 0.2%
(v/w) DTT.
Aliquots were heated in Laemmli buffer containing 50 mM
DTT for 5 min at 95 °C and resolved through 4–12% acrylam-
ide Bis-Tris NuPAGE gels (Invitrogen), and proteins were visu-
alized using a silver staining kit (Thermo Scientific) according
to the manufacturer’s instructions. In-gel tryptic digestion of
dominant bands was undertaken as previously described (34).
To detect pepsin-released collagenous polypeptides, the lyoph-
ilized samples were reconstituted in 0.1 M acetic acid containing
pepsin at 100 g/ml and shaken overnight at 4 °C. After centrifu-
gation at 13,000  g for 15 min, the supernatant was removed,
lyophilized, and resuspended in water before re-lyophilizing and
heating in 20 l of Laemmli buffer containing 50 mM DTT for 5
min at 95 °C. The material was resolved using 3–8% acrylamide
Tris acetate gels (Invitrogen) and silver-stained.
Protein Identification of Bands Using LC-MS/MS—Peptides
were analyzed using a Bruker Amazon ion trapmass spectrom-
eter coupled to a Waters nanoACQUITY UltraPerformance
liquid chromatography system. The sampleswere injected onto
a reverse phase column (Acquity ethylene bridged hybrid C18,
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75 m 150 mm, 1.7 m) and eluted over a 1-h gradient. The
mass spectrometer was set up in positive ion mode and cali-
brated with Bruker calibration mix. Spectra were acquired
between 300 and 1800 m/z with an ion charge count target of
200,000. Up to five precursor ions above a threshold of 10,000
were selected forMSMS fragmentation perMS scan. Each pre-
cursor was fragmented twice, and then the mass was excluded
for 1 min. Singly charged ions were excluded. Data were
searched against the Equus caballus database; Ensembl data-
base for horse (E. caballus; EquCab2.56.pep) using an in-house
Mascot server (Matrix Science, London, UK). Parameters were
set to accept one miscleavage, a fixed modification of carbam-
idomethly cysteine, and a variable oxidation ofmethionine. The
peptide mass tolerance for this instrument was set at 0.4 Da.
Protein In-solution Trypsin Digestion andMass Spectrometry
Using Linear Ion-trap Orbitrap Mass Spectrometer (LTQ-Or-
bitrap Velos)—Proteomic analyses were performed to identify
cellular and matrix proteins present within normal tendon tis-
sue, the relative levels of these proteins, and also to identify
neopeptides of specific ECM proteins. GdnHCl-extracted pro-
teins werewashedwith 100mM ammoniumbicarbonate to give
a final concentration of 0.5 M GdnHCl. Tryptic digestion was
undertaken as previously described (20) but with the addition
of a top-up of a further 2 g after 3 h. LC-MS/MS analysis was
performed using nanoAcquityTM ultraperformance LC
(Waters, Manchester, UK) on-line to an LTQ-Orbitrap Velos
mass spectrometer (Thermo-Fisher Scientific, Hemel Hemp-
stead) as previously described (20) via an electrospray ioniza-
tion ion source containing a 10-m coated Pico-tip emitter
(Presearch LTD, Basingstoke, UK). Aliquots of tryptic peptides
equivalent to 300 ng of tendon fascicle protein were loaded
onto a 180-m  20-mm C18 trap column (Waters) at 5
l/min in 99% solvent A (water plus 0.1% formic acid) and 1%
solvent B (acetonitrile plus 1% formic acid) for 5 min and sub-
sequently back-flushed onto a C18 pre-equilibrated analytical
column (75-m  15-mm Waters) using a flow rate of 0.3
l/min. Xcalibur 2.0 software (Thermo-Electron, Hemel
Hempstead, UK) was used to operate the LTQ-Orbitrap Velos
mass spectrometer in data-dependant acquisition mode. The
survey scanwas acquired in theOrbitrapwith a resolving power
set to 30,000 (at 400 m/z). MS/MS spectra were concurrently
acquired on the 20 most intense ions from the high resolution
survey scan in the LTQmass spectrometer. Charge state filter-
ing 1 was used where unassigned precursor ions were not
selected for fragmentation. Fragmentation parameters in the
LTQmass spectrometer were: normalized collision energy, 30;
activation, 0.250; activation time, 10 ms; minimum signal
threshold, 500 counts with isolation width 2m/z.
Label-free Peptide Quantification—For label-free quantifica-
tion of the tendon fascicles theThermo raw files of the acquired
spectra from in-solution tryptic digests of normal young (n 3)
and old (n  3) equine tendon fascicles were analyzed by the
ProgenesisTM LC-MS software (Version 4, Nonlinear Dynam-
ics) for label-free quantification as previously described (20).
Briefly, after the selection of a reference sample, the retention
times of the other samples were aligned. Feature picking used
the top three spectra for each feature. These were exported
from ProgenesisTM-LC-MS and utilized for peptide identifica-
tion with a locally implementedMascot server (Version 2.3.01)
in the E. caballus database. Search parameters used were: 10
ppm peptide mass tolerance and 0.6-Da fragment mass toler-
ance; onemissed cleavage allowed; fixedmodification, carbam-
idomethylation; variable modifications, methionine oxidation,
proline oxidation, and lysine oxidation. To maximize the num-
ber of quantifiable proteins but simultaneously use an accepta-
ble false discovery rate (FDR), the peptide matches above an
identity thresholdwere adjusted to give an FDRof 1%before the
protein identifications being re-imported into ProgenesisTM.
Mascot determined peptides with ion scores of 20 and above,
and only proteins with at least one unique peptide ranked as the
top candidate were considered and re-imported into Proge-
nesisTM software. For quantification, only unique peptides
were included. Statistical analysis was performed on all
detected features using transformed normalized abundances
for one-way analysis of variance (ANOVA). All peptides (with
Mascot score 23 and p  0.05) of an identified protein were
included, and the protein p value (one-way analysis of variance)
was then performed on the sum of the normalized abundances
for all runs. Adjusted analysis of variance values of p 0.05 and
additionally regulation of 2-fold or 0.5-fold were regarded
as significant.
Neopeptide Identification—For neopeptide determination,
mass spectrometry data from the in-solution tryptic digests of
normal young (n  3) and old (n  3) equine tendon fascicles
were analyzed. Neopeptides were identified by searches against
the Unihorse database using Mascot. Search parameters used
were: enzyme, none; peptidemass tolerances 10 ppm; fragment
mass tolerance of 0.6Da, 1	, 2	, and 3	 ions;missed cleavages
1; instrument type electrospray ionization-TRAP. Modifica-
tions included were; fixed, carbamidomethyl cysteine and vari-
able, oxidation of methionine, proline, and lysine. The proba-
bility that a match was correct (p 0.05) was determined using
the Mascot-derived ion score, where p was the probability that
the observed match was a random event. As the cost of mass
spectrometry analyses of a large number of samples was pro-
hibitive and to have confidence in our analysis, we only
included neopeptides in the results if they were identified by
Mascot more than once per donor and in2 donors. Patterns
of fragmentation were determined for aggrecan, biglycan,
decorin, fibromodulin, COMP, lumican, and collagens.
Gene Ontology, Pathway Enrichment Analysis, and Protein
Network Analysis—The gene symbols for each identified pro-
tein in normal tendon were searched in the Ensembl database
for horse and converted to the gene symbol of the correspond-
ing humanorthologue. The resulting gene list was used for gene
ontology (GO) using the Database for Annotation, Visualiza-
tion, and Integrated Discovery (DAVID) Version 6.7. In addi-
tion, the list was used for protein network analysis with the
Search Tool for Retrieval of Interacting Genes/Proteins
(STRING) tool Version 9.1 (35). The protein interaction maps
were created by allowing for experimental evidence in addition
to the predicted functional links: co-occurrence, co-expression,
databases, and text-mining.
Western Blotting Validation of Fibromodulin Abundance—
To validate the decreased fibromodulin abundance with aging
in normal tendon, soluble proteins were extracted from sepa-
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rate donors (3 young (4 years old) and 3 old (20 years old))
using methods described previously (20). Briefly, 20 g of sol-
uble protein extracts were electrophoresed and separated on
4–12% SDS-PAGE gels (Nu-Page, Invitrogen). Nitrocellulose
membranes were probed with primary antibodies against the
following: mouse polyclonal to fibromodulin (1:2000 dilution,
#67596 Abcam) and -tubulin (1:1000 dilution) (#4074,
Abcam, Cambridge, UK) as the loading control. Membranes
were washed and incubated in a secondary horseradish perox-
idase-conjugated antibody (1:2000 dilution). Blots were imaged
using VisionWorksLS image acquisition software package, and
band densities were analyzed using ImageJ 1.42. Results were
normalized to the loading control.
Real-time Polymerase Chain Reaction (RT-PCR) of Keratin
Expression—Samples of normal SDFT RNA from an indepen-
dent cohort (young, 5.7 1.3 years; old, 23.3 3.1 years (both
n  7)) were used to assess age-related alterations in keratin
gene expression in normal tendon using previously described
methods (36). Exon-spanning primer sequences were designed
and validated by PrimerDesign Ltd (Southampton, UK) except
for the normalization gene glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) (37). The primer pairs were for keratin
type 2, cytoskeletal 75;KRT75 (forward reverse), and keratin
type 2, cytoskeletal 5;KRT5 (forward reverse).
Injured Tendon Study—Injured SDFTs were collected from
young (6.3 2.1 years, n 3) and old horses (19.5 3.5 years,
n  2) euthanized at a commercial equine abattoir. In all ten-
dons injury was localized to the core of the mid-metacarpal
region. All injuries were macroscopically graded as mild-to-
moderate in severity, with the appearance of a hemorrhagic
lesion (38) but without loss of fascicular pattern (39). Fascicles
were dissected from the lesion, proteins were extracted, and
one-dimensional SDS-PAGE was performed as described for
normal tendon. Samples were trypsin-digested and processed
for LCMS-MS as described above. Peptides were quantified
using Progenesis software, and neopeptides were identified.
Protein networks were identified as described above. Due to
normal and diseased samples being run at different times, it was
not possible to directly compare normal and diseased groups.
Statistical Analysis—Statistically significant differences in
the number of proteins and gene expression were identified
after log10 transformation to ensure normal distribution using
Student’s t test. Statistical analyses were undertaken using
S-Plus and Excel software.
RESULTS
SDS-PAGE Comparative Analysis of Protein Extracts—One-
dimensional-SDS-PAGE of the GdnHCl soluble protein
extracts demonstrated differences in the intensity of the stain-
ing between samples fromnormal young and old horses (Fig. 1).
The decreased staining in old samples suggests that the extract-
ability of proteins was reduced in older tendon. However, the
soluble protein concentrations, corrected to wet weight of ten-
don fascicle, did not decrease with increasing age (53  1.2
g/mg for young and 51 0.6 g/mg for old). The major pro-
teins identified in each band using LC-MS/MS are indicated in
Table 1. In addition,weundertook pepsin digestion of the insol-
uble extract remaining after GdnHCl extraction to analyze
non-soluble collagenous polypeptides (19). A number of addi-
tional bands were evident in the pepsin digest of young tendon
(Fig. 2).
Protein Identification and Ontology—A total of 252 proteins
were identified in combined samples from normal tendon; 230
with a significant Mascot score of 23. Supplemental Table 1
FIGURE 1. Silver-stained one-dimensional-SDS-PAGE of the guanidine-soluble protein extract of normal young (n 3) and old (n 3) tendon and
diseasedyoung (n3) andold (n2). Equal protein loadingby volume (20l perwell) allowed aqualitative comparisonof soluble tendonprotein extracts.
The most abundant protein bands are marked with red squares (1–4) were excised from the gel and trypsin-digested, and the protein content of each single
band was analyzed from peptides identified using LC-MS/MS. The black square highlights the additional bands evident in diseased young tendon only.
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provides detailed information on the identification of peptides
mapped to each protein and corresponding Mascot scores.
When the mgf files for each trypsin-digested sample were ana-
lyzed on an individual basis, there was significant variability in
the number of proteins identified in normal young and old ten-
don by Mascot; mean S.E.; young 94.5 8.1 and old 58.6
5.1 proteins; p 0.007.
For normal tendon the total dataset with a significantMascot
scorewas transformed to a non-redundant gene identifier list of
the respective human homologues and then subjected to gene
ontology using DAVID and analysis for protein networks by
STRING.A total of 189 equivocal human gene nameswere used
for bioinformatics analysis. These were classified according to
their GO annotation as intermediate filament 15%, extracellu-
lar matrix 19%, and keratin 12%. DAVID and STRING identi-
fied two significant Kegg pathways from the data set; ECM
receptor interaction and focal adhesion (Bonferroni adjusted p
values of 2.44e13 and 2.61e10, respectively) (supplemental
Table 2). STRING analyses resulted in a loose network of pro-
teins containing two highly connected clusters around collagen
fibril organization and ECM organization (Fig. 3).
Identification of ECM Fragmentation Patterns—A catalogue
of age-related neopeptides was identified for COMP, decorin,
lumican, collagen -2(I), collagen -2(VI), collagen -3(VI),
and collagen -1(XII). These included those identified either in
old normal tendon only, young only, and young and old tendon
(Table 2).
Label-free Relative Quantification—To compare relative pro-
tein levels between normal young and old tendon, samples were
processed for LC-MS/MS, and quantitative analysis was under-
taken with ProgenesisTM. Principal component analysis of all
the peptides identified revealed that the peptides clustered
according to the age of donor, with a principal component of
83%. Levels of 34 proteins differed between young and old ten-
don (25 with 2 peptides). 15 proteins were higher in young
tendon (10 with 2 peptides), and 19 proteins were higher in
old tendon (15 with 2 peptides) (Table 3). STRING analysis
revealed the GO cellular component “intermediate filament”
was significantly increased in old tendon (Bonferroni adjusted p
values 3.7E19). Interestingly, in young tendon the SLRP family
proteins fibromodulin, mimecan (osteoglycin), and asporin
were significantly increased. By contrast, in old tendon, levels of
several cellular proteins were increased, including several cyto-
skeletal keratins and gap junction proteins.
Western Blotting—Western blot analysis of normal young
and old tendon fascicles confirmed the proteomic data by dem-
onstrating a significant reduction in fibromodulin levels in
older tendon (p 0.04; Student’s t test) (Fig. 4).
Differential Gene Expression—To investigate the increase in
keratins in old normal tendon, RT-PCR was undertaken on an
independent cohort of tendon fromnormal young and old donors
using primer pairs for the genes KRT5 and KRT75. There was a
significant increase inexpressionofboth thesegenes inoldnormal
tendonmirroring the protein expression changes (Fig. 5).
TABLE 1
Proteins identified following in-gel trypsin digestion of bands 1–4 of the soluble guanidine extract using LC-MS/MS
The table lists the most prominent proteins identified following significant peptide matches based on Mascot probability based scoring (p 0.05).
Gel
slice
Protein
accession Protein description
Protein
score
Protein
mass
Protein
matches
Protein matches
significant EmPaia
Da
1 F6UW03 Collagen -1(VI) chain 793 110,045 55 38 0.65
F7CGV8 Collagen -2(VI) chain 680 110,009 53 34 0.75
F6QAT0 Collagen -3(VI) chain 177 343,977 21 10 0.07
F6YR34 Thrombospondin-1 111 133,474 5 5 0.08
F7AQV3 Uncharacterized KIAA1211 protein 49 139,560 20 1 0.02
F6U4X2 -Fetoprotein 41 70,131 5 2 0.02
2 F6U3D3 Cartilage oligomeric matrix protein 539 84,675 59 32 0.77
F7E0P3 Thrombospondin-4 69 98,508 11 4 0.08
F7CGV8 Collagen -2(VI) chain 45 110,009 1 1 0.03
F6QAT0 Collagen -1(VI) chain 35 110,045 2 1 0.03
3 F6RZ46 Prolargin 99 43,846 11 3 0.24
F6U4X2 -Fetoprotein 45 70,131 4 3 0.04
A2Q126 Fibromodulin 35 43,407 7 2 0.16
4 O46542 Decorin 152 40,256 27 13 0.88
a Exponentially modified protein abundance index (emPAI) approximates label-free relative quantification of proteins in a mixture based on protein coverage by peptide
matches.
FIGURE2.Theentire guanidine-insoluble, pepsin-releasedmaterial for
each sample was resolved by Tris acetate, 3–8% NuPAGE. The figure
shows representative gels for young and old donors. Polypeptides corre-
sponding to the pepsin-released domains of collagen I(I) (COL1A1), col-
lagen I(2) (COL1A2), collagen V(1) (COL5A1), collagen V(3) (COL5A3),
collagen III(1) (COL3A1) and cross-linked collagen dimers and trimers are
indicated.
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Injured Tendon—Soluble protein content corrected to fasci-
cle wet weight was 34.5 18.3 g/ml in young injured tendon
and 31.4  12.4 in old injured tendon. SDS-PAGE analysis of
guanidine-soluble proteins revealed a greater number of bands
in injured tendon compared with normal (Fig. 1). A total of 278
proteins were identified in combined injured tendon samples;
250 had a significant Mascot score of 19. This was signifi-
cantly greater than the number of proteins identified in normal
tendon (p  0.01). Supplemental Table 1 provides detailed
information on the identification of peptides mapped to each
protein and the corresponding Mascot scores. In diseased ten-
don 188 2 and 150 50 proteinswere identified in young and
old tendon, respectively. A large number of neopeptides were
identified for proteoglycans and collagens in injured tendon,
with many more neopeptides identified in young diseased than
in old diseased samples (Table 2, supplemental Table 3). PCA at
both the peptide (principal component of 36%) and protein
levels revealed separation between young and old samples.
However, the young samples were more tightly clustered than
the old samples. There were 26 proteins at significantly higher
levels in young injured tendon (23 with 2 peptide) (Table 4).
DAVID identified the term acetylation as significantly
increased in this protein set (supplemental Table 4). However,
STRING did not find any protein-protein interaction within
this set.
DISCUSSION
We have performed a comprehensive proteomic analysis of
healthy tendon tissue, identifying age-related alterations to the
proteins present within the tendonmatrix. The results support
FIGURE 3. Protein-protein interactionmap of soluble GdnHCl-extracted proteins in normal tendon. Proteins were input from the total dataset. Unconnected
nodesandproteinsnot relating to the twoclustersofmatrixorganizationalproteinsandcollagenswere removedtoenableclarityof the interactome.Thetotal cluster
wasbuiltwithSTRINGallowing forexperimentally verifiedandpredictedprotein-protein interactionsathighconfidence levels (0.700). Twohighly connectedclusters
were evident.
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the hypothesis demonstrating distinct proteomic profiles in
young and old tendon with decreased levels of several SLRPs
and increases in intermediate filament proteins as a result of
aging. In addition, a number of ECM protein fragments pro-
duced by fragmentation of the original peptide by enzymatic
cleavage between two amino acids, whichwehave termed “neo-
peptides,” were identified in this study, and we propose these
are related to specific cleavage sites. We have also assessed the
proteomic profile of young and old injured tendon, demon-
strating increased matrix fragmentation in disease and distinct
proteomic profiles between age groups.
In both young and old normal samples, STRING analysis of
the proteins present within the GndHCl-soluble extract
revealed two connected clusters of proteins involved in colla-
gen fibril and ECM organization as would be expected in ten-
don tissue. The most abundant collagen identified in the Gnd-
HCl-soluble extract was collagen type VI. Although few studies
have investigated the role of collagen type VI in tendon, Izu et
al. (40) showed that type VI collagen is localized to the pericel-
lular region and is likely to play a role in collagen fibrillogenesis.
Furthermore, it has been demonstrated that collagenVImutant
mice have abnormal collagen fibrils and exhibit muscle and
tendon defects similar to those seen in humanmuscular dystro-
phy (41), suggesting that this minor collagen plays a crucial role
in normal tendon function. A significant role for type VI colla-
gen in tendon function is supported by these data.
Other proteins identified within the GndHCl-soluble extract
include members of the thrombospondin family (COMP,
thrombospondin-4 and -5) and several of the small SLRPs
(decorin, fibromodulin, prolargin). Thrombospondins are
known to regulate cell-matrix interactions, but their specific
role in tendon has not been extensively studied. COMP is
thought to catalyze collagen fibrillogenesis and stabilize the col-
lagen network (42), andCOMP levels have been correlatedwith
tendon mechanical properties (43).
Decorin is the most abundant and the most studied of the
SLRPs within tendon. However, its role is yet to be fully estab-
lished. Both decorin and fibromodulin are involved in fibrillo-
genesis (1), and decorin may also play a role in transfer of force
between collagen fibrils (44), although this function is conten-
tious (45). To the authors’ knowledge this is the first work to
identify the presence of prolargin within tendon tissue. This
class II SLRP is able to bind to type I collagen and is postulated
to anchor basement membranes to the connective tissue (46).
Although there was no overall decrease in the concentration
of soluble proteins extracted from normal tendon with increas-
ing age as determined by the Bradford assay, silver staining of
bands on one-dimensional gels of soluble protein extracts
appeared to decrease with aging. Assessment of the normaliza-
tion factor used by Progenesis during relative quantification
revealed higher normalization factors for old samples even
though a fixed amount of protein (based on Bradford assay
results) was loaded. This suggests that the Bradford assay may
have provided an incorrect estimation of sample protein con-
tent, as reported previously (47), but the reasons for this are
unclear. Taken together, these results suggest that in aged ten-
don protein extractability was reduced, suggesting that the
matrix in aged samples is more resistant to degradation, with
more proteins remaining trapped within the insoluble portion
of the matrix. There were also age-related differences in the
pepsin-released portion of the samples, with more collagenous
polypeptide bands evident in young samples (Fig. 2). These
findings are supported by previous work which has shown that
with aging partially degraded collagen accumulates within the
matrix of the SDFT, which may be due to increased levels of
glycation, rendering the matrix more resistant to degradation
(14).
There were no alterations in the levels of the major matrix
components with increasing age. This supports our previous
studies which have shown that tendon water, collagen, and gly-
cosaminoglycan content of the equine SDFT do not change
with aging (14). However, there was a reduction in levels of
several less-abundant proteins with increasing age in normal
tendon, including several SLRPS (fibromodulin, mimecan,
asporin). The age-related reduction in fibromodulin was fur-
ther confirmed by Western blotting. These proteoglycans
interact with collagen and have all been shown to regulate col-
lagen fibrillogenesis and fibril diameter (1, 48–50). Heat shock
protein 1, also known as heat shock protein 27, also decreased
with aging. Heat shock proteins have anti-apoptotic and anti-
TABLE 2
Number of neopeptides identified in normal old tendon only, young
tendon only, and young and old tendon
Neopeptides were identified by Mascot with a significant score more than once per
donor and in2 donors. Numbers in parentheses indicate number of peptides also
identified in diseased tendon. For full details of neopeptide sequences, see supple-
mentary information (supplemental Table 3).
Condition Protein
Number of
neopeptides identified
Normal tendon
Old tendon only Decorin 1 (1)
COMP 4 (2)
Col1A2 1
Col6A2 1
Col6A3 2
Col12A1 2
Young tendon only Decorin 1 (1)
COMP 6 (2)
Lumican 1
Col6A3 7 (1)
Col12A1 6 (1)
Young and old tendon Decorin 2 (2)
COMP 2 (1)
Lumican 1
Col6A2 1
Col6A3 1
Diseased tendon
Old tendon only Biglycan 4
Lumican 2
Col6A1 1
Col6A3 2
Young tendon only Aggrecan 4
Biglycan 5
COMP 18 (1)
Decorin 15 (2)
Fibromodulin 2
Lumican 4
Col6A1 3
Col6A2 6
Col6A3 12 (1)
Col12A1 1 (1)
Col14A1 1
Young and old tendon Biglycan 2
COMP 5 (2)
Decorin 6 (2)
Lumican 2
Col6A1 2
Col6A3 4
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inflammatory roles and have also been shown to increase in
tendinopathy, where it is suggested they may play a role in ten-
don healing (51). The reduction in levels of these proteins with
agingmay, therefore, affectmaintenance and repair ofmatrix in
old tendon and could contribute to the increased risk of tendon
injury in aged individuals.
There were also alterations in levels of several cellular pro-
teins with aging, with decreases in histones and integrins and
increases in keratins and gap junction proteins with aging. Pre-
vious studies have shown that cellularity within the SDFT does
not change with aging (12), suggesting that these alterations
may reflect an age-related change in cell phenotype. Themajor-
ity of proteins that increased with age were keratins and gap
junction proteins. Although some cuticular keratins were iden-
tified, possibly due to contamination from hair during dissec-
tion, the majority of keratins identified were cytoskeletal, and
their increase was confirmed at the gene expression level.
STRING analysis revealed these proteins belong to the GO cel-
lular component intermediate filament. These filaments form
cytoskeletal networks that are important in maintenance and
regulation of cell tension, providing support for the plasma
membrane during contact with cells and extracellular matrix
(52). The increases in intermediate filament proteins observed
with aging may indicate an increase in cell stiffness, which
could result in an altered cell response to tensile loading in aged
tendons. Although the specific roles of cytoskeletal keratins in
tendon are not well understood, it has been previously demon-
strated that keratin 1 and 10 are localized to the basement
membrane epithelium recently identified around tendon (53).
This basement membrane is thought to regulate cell migration
and maintain tendon functional integrity (53). A change in the
levels of cytoskeletal components suggests differences in their
mechanical behavior with aging.
In addition, a number of previously documented as well as
novel neopeptides were identified in this study. It is likely that
those found in both young and old normal samples could be due
to normal ECM turnover.However, theymay represent proteo-
lytic cleavage occurring as a consequence of subclinical patho-
logical degradation, or they could be neopeptides produced
during tissue processing as cell death can release intracellular
proteases. Protease activity during processing seems unlikely as
attempts to mitigate this were made through the chilling and
rapid post-mortem dissection of the limbs and snap-freezing of
tissues.
It could be hypothesized that the neopeptides identified in
normal young tendon alone represent ECM fragments pro-
duced by normal tissue remodeling, which is altered with aging
and injury. We identified the COMP neopeptide NTVMEC-
DACGMQP2A in young tendon only. This cleavage pattern
has been attributed to the activity of a disintegrin with
thrombospondin motifs (ADAMTS)-5 in mouse.5 Con-
versely, although a greater number of neopeptides were iden-
tified in young than in old tendon, neopeptides present only in
5 P. Holden, personal communication.
TABLE 3
Anumber of differentially abundantproteinswere identifiedbyProgenesisTM LC-MS softwarebetweenyoungandold tendon.All proteinswith
a>2-fold change in normalized abundance are shown
A value of infinity is given when no peptides for a given protein in the group other than the highest mean condition were identified.
Highest mean
condition Accession Description Role
Peptide
count
Max -fold
change
ANOVA
p
Young XP_001503038.3 Protein disulfide-isomerase A3 isoform 1 ER enzyme-protein folding 2 Infinity 0.003
XP_001491653.1 Asporin isoform 1 SLRP-collagen interaction 2 264.2 0.03
XP_001916358.2 Neuroblast differentiation-associated
protein AHNAK
Cell proliferation/differentiation 3 83.6 0.027
XP_001497470.1 Histone H2B type 1-M isoform 1 DNA packaging protein 10 54.8 0.002
XP_001500135.1 Histone H2B type 2-F DNA packaging protein 10 54.5 0.006
XP_001918010.1 Mimecan SLRP-collagen interaction 4 29.4 0.002
NP_001075246.1 Fibromodulin SLRP-collagen interaction 14 21 0.008
XP_001504528.1 Heat shock protein -1 Antiapoptotic and anti-inflammatory 2 10.5 0.003
XP_001915599.1 UPF0293 protein C16orf42 Unknown 1 Infinity 0.031
XP_001493624.2 ras-related C3 botulinum toxin substrate 1 Cell growth, cytoskeletal organization 1 Infinity 0.004
XP_001490052.2 Integrin -2 Cell attachment 1 Infinity 0.003
XP_001500627.1 Spectrin  chain, brain isoform 1 Cytoskeletal protein 1 Infinity 0.001
XP_001496993.1 Peptidyl-prolyl cis-trans isomerase A isoform 1 Enzyme-protein folding 1 666.2 0.009
Old XP_001504448.1 Keratin, type II cytoskeletal 75 isoform 1 Intermediate filament protein 11 Infinity 0.001
XP_001497733.1 Keratin, type I cuticular Ha5 Intermediate filament protein 5 Infinity 0.001
XP_001504468.1 Keratin, type II cytoskeletal 5 isoform 1 Intermediate filament protein 14 20 0.027
XP_001504484.1 Keratin, type II cytoskeletal 73 isoform 1 Intermediate filament protein 8 16.6 0.047
XP_001917840.1 Junction plakoglobin Cell junction protein 2 9.9 0.049
XP_001499854.1 Keratin, type I cytoskeletal 10 Intermediate filament protein 24 8.9 0.012
XP_001496987.1 Keratin, type I cytoskeletal 14 Intermediate filament protein 10 8.9 0.006
XP_001489373.1 Major allergen Equ c 1 Transporter protein 2 8.5 0.003
XP_001504488.2 Keratin, type II cytoskeletal 2 epidermal Intermediate filament protein 11 7.3 0.026
XP_001494629.3 Keratin, type II cytoskeletal 1 Intermediate filament protein 12 6.3 0.032
XP_001494427.2 Keratin, type II cuticular Hb5 Intermediate filament protein 12 4 0.029
XP_001504460.2 keratin, type II cytoskeletal 6B Intermediate filament protein 14 3.6 0.016
XP_001916241.2 Desmoglein-1 Cell junction protein 2 2.1 0.012
XP_001916548.2 Desmoplakin Cell junction protein 1 Infinity 0
NP_001093583.1 Secretory phospholipase A2 Lipid metabolism 1 7091.7 0.009
NP_001075966.1 Major allergen Equ c 1 precursor Transporter protein 1 779.5 0.001
XP_001502526.1 arf-GAP with SH3 domain, ANK repeat and
PH domain-containing protein 2
Vesicular transport 1 5.6 0.005
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old tendonmay represent important events in tendon aging and
provide an insight into the underlying mechanisms that conse-
quently increase the risk of tendon injury in aged individuals.
Interestingly the COMP neopeptides F2CFSQENIIWANLR
andC2PDGTPSPCHEK, identified in old healthy tendon only,
have been recently identified within equine SDFT tissue (18).
The neopeptide F2CFSQENIIWANLR was evident in sub-
acute SDFT injury and also after IL-1 stimulation of macro-
scopically normal equine SDFT explants. One proposed theory
of aging is the “senescent secretory phenotype” (54). Accumu-
lation of specific cells, which secrete increased amounts of cyto-
kines, contributes to cell aging. The identification of this neo-
peptide in both studies could indicate that there may be
enhanced production of cytokines in tendon aging. This could
provide a direct link between aging and inflammation similar to
that proposed in cartilage (55).
In the study byDakin et al., C2PDGTPSPCHEKwas evident
in both normal SDFT and in control explants maintained in
culture for 24 h (11). Due to the wide age range used in their
study, it would be interesting to undertake further work to
assess if this neopeptide represents a specific aging biomarker
and if so, at which age it appears.
Anumber of collagenneopeptideswere also identified. Inter-
estingly we previously proposed that an inability to remove par-
tially degraded collagens from the tendon matrix may lead to
reducedmechanical competence in aging tendon (14). The col-
lagen I, VI, and XII neopeptides identified here in only the old
normal tissue could support this hypothesis. In young tendon a
number of collagen VI and XII fragments were also evident.
This could be explained by the role of collagenVI in fibrillogen-
esis (40) and collagen XII in ECM organization (56) and repre-
sent normal matrix turnover due to weaker ECM interactions
of these collagens in young tendon. Indeed, in developing chick
tendon it has been demonstrated that collagen VI is predomi-
nantly located to the interfascicular matrix (56). This is inter-
esting as our previous work has shown that the interfascicular
matrix plays an important role in SDFT function but becomes
stiffer in aged tendon (30, 57), which may be due to a reduced
ability to turn over this matrix with aging.
It was not possible to directly compare the proteome of nor-
mal and injured tendon, as these samples were analyzed at dif-
ferent times. However, there are some clear differences
between normal and injured states. Although the soluble pro-
tein content was lower, a greater number of proteins were iden-
tified in injured tendon compared with normal. This may be
because soluble protein content was normalized to fascicle wet
weight; it has previously been shown that tendinopathic tissue
has a higher water content than normal tendon (58), which
would result in a relatively lower protein content when normal-
izing to wet weight. Furthermore, additional bands were visible
in samples from injured tendon, which are likely to be due to
increased matrix degradation and fragmentation (Fig. 1). An
increase in cellularity may also contribute to the increase in the
number of proteins identified in injured tendon. Many of the
proteins identified in diseased tendon were cellular, and it is
well established that cell numbers are increased in injured ten-
don (59–61). Furthermore, a larger number of neopeptides
were identified in injured tendon, indicating a greater degrada-
tion of collagens and proteoglycans with disease.
It is also apparent that the proteomic profile differs with age
in injured tendon. A number of proteins were detected at
higher levels in young compared with old diseased tendon.
These include several cellular proteins, which have roles in pro-
tection of cells from stress and synthesis and stabilization of
matrix proteins (see Table 5). Furthermore, several of these
proteins have been identified in developing tendon (25) and in
artificially induced tendon lesions (24). The higher levels of
these proteins in young diseased tendon may, therefore, repre-
sent a healing response, which appears to be limited in old dis-
eased tendon (63). A larger number of neopeptides was also
identified in young injured tendon, suggesting a greater ability
to degrade damaged regions of the matrix. This may further
explain why aged tendons are more at risk of injury, as a failed
healing response is likely to lead to the accumulation of
microdamage and subsequent injury. However, it is unclear if
this failed healing response is due to a decreased ability of ten-
don cells to synthesize and degrade damaged regions of the
matrix in aged tendons or whether the matrix is more resistant
to degradation due to age-related glycation.
There are several limitations to this study that need to be
considered. The high levels of collagenous proteins in tendon
mean that it is difficult to detect proteins present at a low abun-
dance. Future studies could use hexapeptide peptide library
protein normalization (62), which would allow identification of
FIGURE 4. Effect of age on fibromodulin levels in tendon fascicles. A, rep-
resentative blots of fibromodulin and -tubulin in samples from young and
old horses. B, Western blot analysis of fibromodulin normalized to -tubulin
demonstrated a significant reduction in fibromodulin with age. The histo-
gram represents mean pixel intensityS.E., n 3; *, p 0.05.
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low abundance proteins. Alternatively, absolute protein quan-
tification using QconCat technology could be used in an artifi-
cially aged in vitromodel (20), whichwould allow the analysis of
a greater number of samples. In addition, proteins present may
not have been identified as they could not be extracted from the
matrix, which is highly resistant to degradation. Furthermore, it
is evident that protein extractability is altered with aging in
normal tendon; therefore, some of the age-related alterations
identified could be because the proteins were not extracted
from the matrix. However, if this were the case it would be
expected there would be a global decrease in protein levels with
aging, whichwas not observed. It should also be considered that
some of the proteins identified, particularly keratinous pro-
teins, may be due to contamination from skin and hair. Care
was taken during dissection to ensure minimal contamination,
and as the majority of keratins identified were cytoskeletal
rather than cutaneous, this is unlikely to be a major source of
contamination. Furthermore, we have confirmed the increased
keratin levels with aging at the mRNA level.
CONCLUSIONS
Although proteomic analysis is fast becoming a standard
technique to study many soft tissues, few studies have
attempted to use this technique to characterize tendon tissue.
In the current study we have demonstrated age-related altera-
tions in several proteins within normal tendon, with decreases
in proteins that play a role in ECM organization and increases
in cytoskeletal proteins. We have further demonstrated an
altered proteomic profile in injured tendon, with significantly
more proteins identified and a greater degree of matrix frag-
mentation. We have also shown a decrease in levels of proteins
associated with reduction of cell stress and increased matrix
synthesis with aging in injured tendon. This study has increased
FIGURE 5. Gene expression of KRT5 and KRT75 in normal young and old tendon. Data are represented as 2 
Ct (2ˆ-DCT) compared with GAPDH.
Histograms represent the means S.E. of mean. *, p 0.05. Data were evaluated using Student’s t test after log transformation for normalization (n 7).
TABLE 4
A number of differentially abundant proteins were identified by ProgenesisTM LC-MS software between diseased young and old tendon
All proteins with a2-fold change in normalized abundance are shown. All proteins were at higher levels in the young diseased tendon.
Accession Description Role
Peptide
count
Max fold
change
ANOVA
(p)
XP_001490861.2 Cofilin-2 Actin disassembly 2 631.4 0.003
XP_001493508.1 Tenascin-N Facilitates neural growtha 4 18.2 0.019
XP_001501829.1 -Crystallin B chain Increase cell tolerance to stressa,b 8 12.7 0.004
XP_001503950.1 Tubulointerstitial nephritis antigen 1 isoform 1 Cysteine peptidase-ECM turnover 2 7.4 0.004
NP_001075421.1 -Fetoprotein precursor Plasma proteina 1 5.1 0.017
XP_001503085.1 Actin, aortic smooth muscle isoform 1 Cell motility 20 5.1 0.015
XP_001915023.1 Cysteine-rich protein 2 Inhibits inflammatory pain 1 5.0 0.009
XP_001917554.1 Procollagen C-endopeptidase enhancer 2 Enhances cleavage of pro-collagena,b 3 4.4 0.003
XP_003363861.1 Heat shock 70-kDa protein 1 Protects cells from thermal stress 4 4.2 0.004
XP_001503538.2 Target of Nesh-SH3 isoform 4 ECM organisation 1 3.3 0.001
XP_001916170.2 protein SZT2 Involved in oxidative stress 5 3.2 0.020
XP_001915664.2 Microfibrillar-associated protein 5 Associates with elastic fibres, stabilizes procollagen 2 3.1 0.050
XP_001494523.1 Polymerase I and transcript release factor isoform Transcription regulation 9 3.0 0.029
XP_001916600.1 Insulin growth factor binding protein-6 Carrier protein for IGF-1 3 3.0 0.033
NP_001229384.1 SH3 domain binding glutamic acid-rich protein like 3 Nuclear/cytoplasmic protein 3 2.9 0.004
XP_001503725.1 Annexin A6 Regulation of membrane traffic 4 2.8 0.025
XP_001498580.3 Integrin -V Cell-cell & cell-matrix interactionsa 3 2.6 0.009
XP_001914753.2 Catalase Prevents cells from oxidative damage 22 2.5 0.007
XP_001914918.2 Fibulin-2 Interacts with elastic fibres 13 2.3 0.030
XP_001504528.1 Heat shock protein 1 Protects cells from thermal stress 7 2.2 0.043
XP_001916279.2 ATP synthase subunit , mitochondrial ATP synthesis 4 2.1 0.032
XP_001496987.1 Keratin, type I cytoskeletal 14 Intermediate filament proteina 3 2.0 0.002
a Previously identified in developing tendon (25).
b Previously identified in healing tendon (24).
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the knowledge ofmolecular events associated with tendon deg-
radation characteristic of aging and injury and identified pep-
tides that may be useful as biomarkers of tendon injury. These
findings suggest that maintenance and repair of tendon tissue
may be reduced in aged individuals, resulting in an impaired
healing response, andmay help to explain why the risk of injury
increases with aging.
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